Microglial Contributions to MEF2C Haploinsufficiency Syndrome
小胶质细胞对 MEF2C 单倍体不足综合征的贡献
基本信息
- 批准号:10240621
- 负责人:
- 金额:$ 5.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAllelesBehaviorBehavioralBrainCell DensityCell LineageCell physiologyCellsCenters for Disease Control and Prevention (U.S.)ChildChromosome 5Chromosome abnormalityCommunicationDataDevelopmentDiseaseEpilepsyEthicsExhibitsExonsExperimental DesignsEyeFDA approvedFellowshipFemaleFunctional disorderGene ExpressionGenesGeneticGoalsHeritabilityHeterozygoteHumanHyperactive behaviorImmuneImmune systemIndividualIntellectual functioning disabilityInvestigationKnowledgeLaboratoriesLeadLearningLinkLiteratureMeasuresMedicalMemoryMicrogliaModelingMolecular AbnormalityMotorMovementMusMutationNeurodevelopmental DisorderNeuroimmuneNeuroimmunomodulationNeuronsOntologyPatientsPhenotypePhysiciansPhysiologyPopulationPrevalenceRegulationResearchResearch PersonnelResearch TrainingRoleScholarshipScientistSeizuresShapesSocial BehaviorSocial InteractionSouth CarolinaSpeechSymptomsSyndromeTrainingUltrasonicsUniversitiesautism spectrum disorderautisticbasebehavior influencebehavior testbehavioral phenotypingbrain cellcell typecollaborative environmentimmunoreactivityinvestigator trainingmalemouse modelmyocyte-specific enhancer-binding factor 2neural circuitpublic health relevancerepetitive behaviorsexskillssocial communicationsymptom clustertranscription factortranscriptome sequencingtrendvocalization
项目摘要
MEF2C Haploinsufficiency Syndrome (MHS) is a debilitating neurodevelopmental disorder related to autism
spectrum disorders (ASD). Core symptoms of social/communication deficits and repetitive/fixed behaviors define
ASD. MHS is an ASD-related syndrome characterized by ASD symptoms, such as poor reciprocal social
behavior, lack of speech, and repetitive behaviors. In addition to ASD symptoms, intellectual disability, seizures,
and motor movement issues are also observed in MHS patients. MHS is genetically linked to mutations and
deletions in one of the two copies of the MEF2C gene on chromosome 5, termed MEF2C haploinsufficiency.
There are currently no FDA approved treatments for MHS, and there is a need for more knowledge of the
mechanisms behind this syndrome. Mouse models to study this syndrome have been developed, in which one
copy of the Mef2c gene has a deletion in exon 2 (Mef2C+/- mice), termed Mef2c heterozygosity. These mice
exhibit behaviors reminiscent of MHS, including social interaction and communication deficits. Most studies into
MHS have focused on neurons in the brain but, not microglia, which also express MEF2C. In addition to clearing
brain debris, microglia, the resident immune cells of the brain, have been observed shaping neural and synaptic
circuitry. Since microglia also express MEF2C and have pivotal functions in the brain, the goal of this proposed
fellowship is to investigate the possible contributions that microglia could have on MEF2C Haploinsufficiency
Syndrome-related phenotypes. We hypothesize that Mef2c heterozygosity leads to changes in microglial cell
physiology, which results in aberrant behavioral phenotypes. I plan to use mouse models through two aims to
examine this hypothesis. Specific aim 1 plans to determine the role of Mef2c in microglial activation and microglial
gene expression. Aim 1 proposes to study this activation in mice that are heterozygous for Mef2c in a restricted
population, which includes microglia in the brain. In addition to confirming possible microglial activation, aim 1
proposes to study possible functional changes in Mef2C+/- microglia through RNA-sequencing and subsequent
gene ontology analysis. Specific aim 2 proposes to characterize MEF2C Haploinsufficiency Syndrome-related
behaviors in mice heterozygous for Mef2c in microglia. Expected results include findings that microglia in these
mouse models have increased activation and changes in microglial function. If behavior deficits are seen in the
microglia-restricted Mef2c mice, this could explain a cell type-specific neuroimmune mechanism of MHS. This
proposed fellowship would assist the investigator in achieving her goal to become a physician-scientist. The
background and training potential of the investigator is outlined in this fellowship application. This proposal is
uniquely suited to the training needs of this investigator, including training in experimental design, technical
laboratory skills, scholarship, and ethics. This research and training will be performed at the Medical University
of South Carolina, which has a collaborative environment and many facilities to support the investigator’s training.
MEF2C单倍症综合征(MHS)是与自闭症有关的令人衰弱的神经发育障碍
频谱障碍(ASD)。社会/沟通缺陷和重复/固定行为的核心症状定义
ASD。 MHS是一种与ASD相关的综合症,其特征是ASD符号,例如贫穷的互惠社交
行为,缺乏言语和重复行为。除了ASD症状,智力残疾,癫痫发作,
在MHS患者中还观察到运动问题。 MHS遗传与突变有关
在5染色体上的MEF2C基因的两个副本之一中删除,称为MEF2C单倍宽度。
目前尚无FDA批准的MHS治疗方法,并且需要更多了解
该综合征背后的机制。已经开发了研究该综合征的小鼠模型,其中一个
MEF2C基因的副本在外显子2(MEF2C +/-小鼠)中具有删除,称为MEF2C杂合性。这些老鼠
表现出使人联想到MHS的行为,包括社会互动和沟通不足。大多数研究
MHS专注于大脑中的神经元,而不是表达MEF2C的小胶质细胞。除了清理
已经观察到脑碎屑,小胶质细胞,大脑的常驻免疫细胞,已观察到塑造神经和突触
电路。由于小胶质细胞也表达MEF2C并在大脑中具有关键功能,因此该提案的目的
奖学金是为了调查小胶质细胞可能对MEF2C单倍不足的可能贡献
综合征相关的表型。我们假设MEF2C杂合性导致小胶质细胞的变化
生理学,导致行为表型异常。我计划通过两个目标使用鼠标模型
检查这个假设。具体目标1计划确定MEF2C在小胶质细胞激活和小胶质细胞中的作用
基因表达。目标1在受限的MEF2C杂合的小鼠中研究这种激活的建议
种群,包括大脑中的小胶质细胞。除了确认可能的小胶质激活外,AIM 1
通过RNA序列和后续的提议研究MEF2C +/-小胶质细胞可能的功能变化
基因本体分析。特定的目标2建议MEF2C单倍症综合征与与
小胶质细胞中MEF2C的小鼠的行为。预期结果包括其中的小胶质细胞
小鼠模型的激活和小胶质功能的变化增加。如果行为定义在
小胶质细胞限制的MEF2C小鼠,这可以解释MHS的细胞类型特异性神经免疫性机制。
拟议的奖学金将帮助调查人员实现她成为身体科学家的目标。
在此奖学金申请中概述了研究人员的背景和培训潜力。该提议是
独特地适合该调查员的培训需求,包括实验设计培训,技术
实验室技能,科学和道德。这项研究和培训将在医科大学进行
南卡罗来纳州的摄于协作环境和许多设施,以支持调查人员的培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine M Bridges Adams其他文献
Catherine M Bridges Adams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine M Bridges Adams', 18)}}的其他基金
Microglial Contributions to MEF2C Haploinsufficiency Syndrome
小胶质细胞对 MEF2C 单倍体不足综合征的贡献
- 批准号:
9760727 - 财政年份:2019
- 资助金额:
$ 5.01万 - 项目类别:
Microglial Contributions to MEF2C Haploinsufficiency Syndrome
小胶质细胞对 MEF2C 单倍体不足综合征的贡献
- 批准号:
10017058 - 财政年份:2019
- 资助金额:
$ 5.01万 - 项目类别:
相似国自然基金
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
- 批准号:82200258
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
- 批准号:82171845
- 批准年份:2021
- 资助金额:54.00 万元
- 项目类别:面上项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
- 批准号:
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
- 批准号:32102530
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别:
Multi-omic phenotyping of human transcriptional regulators
人类转录调节因子的多组学表型分析
- 批准号:
10733155 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
- 批准号:
10658665 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别: